Bertin Pharma en INDIGO Biosciences tekenen overeenkomst over distributie testkits voor nucleaire receptoren in Europa
MONTIGNY-LE-BRETONNEUX, Frankrijk–(BUSINESS WIRE)– Europese onderzoekers kunnen vanaf nu beschikken over meer dan veertig productreferenties voor nucleaire receptoren, die van belang zijn voor medicijnontwikkeling en toxicologisch onderzoek.
INDIGO Biosciences, toonaangevend in onderzoek naar nucleaire receptoren, biedt ‘s werelds grootste portefeuille testkits voor nucleaire receptoren aan. De testkits maken gebruik van een signaleringstechnologie met luciferase. De kits zijn all-inclusive, gericht op cellen, robuust en gebruiksklaar voor de screening van een klein aantal testsamenstellingen of HTS-toepassingen.
Bertin Pharma and INDIGO Biosciences Sign Agreement for Distributing Nuclear Receptor Assay Kits in Europe
MONTIGNY-LE-BRETONNEUX, France–(BUSINESS WIRE)– Over 40 product references to assay nuclear receptors are now available for European researchers during their work in drug discovery and toxicology. These innovative tools are used for profiling compounds in research areas such as metabolic disorders, cardiovascular disease, or even endocrinology.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161114006168/en/
Nuclear Receptor Assay kits distributed in Europe via Bertin Pharma and INDIGO Biosciences agreement (Photo: INDIGO Biosciences)
Innovative products to reduce time, cost and risk in drug discovery process
INDIGO Biosciences, leader in Nuclear Receptor Research, provides the world’s largest portfolio of Nuclear Receptor Assay kits using luciferase reporter technology. Those kits are all-inclusive, cell-based, robust, and ready to use for either screening small numbers of test compounds or HTS application.
Expansion to Europe
With a fast-growing business in the USA, INDIGO Biosciences wishes to benefit from increased European exposure to capture new market shares.
Bertin Pharma is one of the major European players for the supply of reagents and assay kits dedicated to the research and development for the pharmaceutical, cosmetic and food industries. Bertin Pharma has marketed biological reagent ranges for over 25 years. Its long R&D experience combined with its International distributor channels enable to deliver life science tools on time and to support customers throughout their experimentation.
Bertin Pharma completes, with this new range of Nuclear Receptor Assay kits, its existing ranges of biomarker assays applied to his expertise areas that are metabolic syndrome, hypertension or even oncology.
“ It has been a real honor to be introduced to Fred and his company and we rapidly found a lot of complementarity in our business. The Nuclear Assay range perfectly fit with our customer’s needs, and will empower our commercial activity.” Said Patrick Vitaux, Bioreagent Dpt Manager – Bertin Pharma
“We are pleased to have reached an agreement with Bertin Pharma to expand our distribution network in Europe. We look forward to working with Patrick and his team to bring INDIGO’s assay portfolio to their customers throughout the region.” Fred Marroni, CEO – INDIGO Biosciences
About INDIGO Biosciences
Learn more about INDIGO Bioscience
About Bertin Pharma
Learn more about Bertin Pharma
View source version on businesswire.com: http://www.businesswire.com/news/home/20161114006168/en/
Contacts
INDIGO Biosciences
Fred Marroni (814)234-1919
or
Bertin Pharma
Frédérique Vigezzi – Gootenberg, +33 (0)143 59 2984